Ethema Health Corporation (GRST)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.34 Million USD | 10.87% |
| 2022 | 4.82 Million USD | 148.16% |
| 2021 | 1.94 Million USD | 473.04% |
| 2020 | 338.99 Thousand USD | -5.82% |
| 2019 | 359.94 Thousand USD | -16.78% |
| 2018 | 432.51 Thousand USD | -53.46% |
| 2017 | 929.41 Thousand USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 3.13 Million USD | -8.12% |
| 2014 | 3.41 Million USD | -42.7% |
| 2013 | 5.96 Million USD | 7.61% |
| 2012 | 5.54 Million USD | 230.05% |
| 2011 | 1.67 Million USD | 778.0% |
| 2010 | 191.2 Thousand USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2001 | 4.82 Million USD | -73.85% |
| 2000 | 18.43 Million USD | 11.43% |
| 1999 | 16.54 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.49 Million USD | 14.61% |
| 2024 Q1 | 1.3 Million USD | 15.56% |
| 2023 Q2 | 1.56 Million USD | 20.45% |
| 2023 Q1 | 1.3 Million USD | 5.31% |
| 2023 FY | 5.34 Million USD | 10.87% |
| 2023 Q4 | 1.12 Million USD | -16.9% |
| 2023 Q3 | 1.35 Million USD | -13.54% |
| 2022 Q3 | 1.42 Million USD | 25.21% |
| 2022 FY | 4.82 Million USD | 148.16% |
| 2022 Q4 | 1.23 Million USD | -13.37% |
| 2022 Q2 | 1.13 Million USD | 11.21% |
| 2022 Q1 | 1.02 Million USD | 15.08% |
| 2021 Q1 | 90.79 Thousand USD | 8.96% |
| 2021 Q4 | 889.2 Thousand USD | 2.63% |
| 2021 FY | 1.94 Million USD | 473.04% |
| 2021 Q3 | 866.43 Thousand USD | 801.05% |
| 2021 Q2 | 96.15 Thousand USD | 5.91% |
| 2020 FY | 338.99 Thousand USD | -5.82% |
| 2020 Q4 | 83.32 Thousand USD | -7.24% |
| 2020 Q3 | 89.82 Thousand USD | 9.15% |
| 2020 Q2 | 82.3 Thousand USD | -1.49% |
| 2020 Q1 | 83.54 Thousand USD | 163.51% |
| 2019 Q1 | 82.01 Thousand USD | 559.44% |
| 2019 Q4 | 31.7 Thousand USD | -78.59% |
| 2019 FY | 359.94 Thousand USD | -16.78% |
| 2019 Q2 | 98.18 Thousand USD | 19.72% |
| 2019 Q3 | 148.04 Thousand USD | 50.78% |
| 2018 Q3 | 270.37 Thousand USD | 305.39% |
| 2018 Q1 | 113.3 Thousand USD | 125.54% |
| 2018 Q2 | 66.69 Thousand USD | -41.14% |
| 2018 Q4 | -17.85 Thousand USD | -106.6% |
| 2018 FY | 432.51 Thousand USD | -53.46% |
| 2017 Q4 | -443.61 Thousand USD | -168.43% |
| 2017 FY | 929.41 Thousand USD | 0.0% |
| 2017 Q3 | 648.29 Thousand USD | 61.18% |
| 2017 Q2 | 402.22 Thousand USD | 24.72% |
| 2017 Q1 | 322.51 Thousand USD | 111.03% |
| 2016 Q2 | 1.02 Million USD | 24.49% |
| 2016 FY | - USD | -100.0% |
| 2016 Q4 | -2.92 Million USD | -371.63% |
| 2016 Q1 | 822.83 Thousand USD | 24.4% |
| 2016 Q3 | 1.07 Million USD | 5.07% |
| 2015 FY | 3.13 Million USD | -8.12% |
| 2015 Q2 | 947.93 Thousand USD | 39.26% |
| 2015 Q3 | 848.76 Thousand USD | -10.46% |
| 2015 Q4 | 661.46 Thousand USD | -22.07% |
| 2015 Q1 | 680.71 Thousand USD | 12.81% |
| 2014 Q2 | 1.64 Million USD | 43.98% |
| 2014 FY | 3.41 Million USD | -42.7% |
| 2014 Q4 | 603.4 Thousand USD | -49.6% |
| 2014 Q3 | 1.19 Million USD | -27.05% |
| 2014 Q1 | 1.13 Million USD | -11.22% |
| 2013 Q4 | 1.28 Million USD | -24.71% |
| 2013 Q3 | 1.7 Million USD | 11.53% |
| 2013 FY | 5.96 Million USD | 7.61% |
| 2013 Q1 | 1.44 Million USD | -9.71% |
| 2013 Q2 | 1.52 Million USD | 5.86% |
| 2012 Q3 | 1.33 Million USD | -0.96% |
| 2012 FY | 5.54 Million USD | 230.05% |
| 2012 Q4 | 1.59 Million USD | 19.75% |
| 2012 Q1 | 1.25 Million USD | 90.12% |
| 2012 Q2 | 1.34 Million USD | 7.25% |
| 2011 Q2 | 286.92 Thousand USD | 28.21% |
| 2011 Q4 | 661.37 Thousand USD | 30.52% |
| 2011 Q3 | 506.71 Thousand USD | 76.6% |
| 2011 Q1 | 223.78 Thousand USD | 104.72% |
| 2011 FY | 1.67 Million USD | 778.0% |
| 2010 FY | 191.2 Thousand USD | 0.0% |
| 2010 Q4 | 109.31 Thousand USD | 43.96% |
| 2010 Q3 | 75.93 Thousand USD | 1173.16% |
| 2010 Q2 | 5964.00 USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2001 Q3 | 1.98 Million USD | 57.14% |
| 2001 Q4 | 190 Thousand USD | -90.4% |
| 2001 FY | 4.82 Million USD | -73.85% |
| 2001 Q2 | 1.26 Million USD | -9.35% |
| 2001 Q1 | 1.39 Million USD | -85.46% |
| 2000 FY | 18.43 Million USD | 11.43% |
| 2000 Q2 | 2.58 Million USD | 3.2% |
| 2000 Q3 | 3.79 Million USD | 46.9% |
| 2000 Q4 | 9.56 Million USD | 152.24% |
| 2000 Q1 | 2.5 Million USD | 0.0% |
| 1999 FY | 16.54 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| The Amacore Group, Inc. | 28.82 Million USD | 81.46% |
| Arem Pacific Corporation | 343.47 Thousand USD | -1456.129% |
| Assisted 4 Living, Inc. | 880.78 Thousand USD | -506.844% |
| BioCorRx Inc. | 89.16 Thousand USD | -5894.814% |
| Bionik Laboratories Corp. | 1.8 Million USD | -196.087% |
| Banyan Corp. | 5 Million USD | -6.821% |
| Clearday, Inc. | 12.48 Million USD | 57.201% |
| Dental Patient Care America, Inc. | 3.24 Million USD | -64.663% |
| Quantum Medical Transport, Inc. | 1310.14 USD | -407869.835% |
| Empower Clinics Inc. | 4.66 Million USD | -14.662% |
| First Choice Healthcare Solutions, Inc. | 29.98 Thousand USD | -17725.499% |
| Selectis Health, Inc. | 36.78 Million USD | 85.469% |
| HealthLynked Corp. | 5.72 Million USD | 6.595% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.24 Million USD | 42.209% |
| JRSIS Health Care Corporation | 3.46 Million USD | -54.393% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 453.75 Million USD | 98.822% |
| MedSmart Group Inc. | - USD | -Infinity% |
| North America Frac Sand, Inc. | 137.3 Thousand USD | -3792.776% |
| Nova Leap Health Corp. | 26.17 Million USD | 79.583% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | -1419.914% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | 49.104% |
| Raffles Medical Group Ltd | 536.52 Million USD | 99.004% |
| Ryman Healthcare Limited | 650.53 Million USD | 99.178% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 4.61 Million USD | -15.853% |
| Mycotopia Therapies, Inc. | - USD | -Infinity% |
| U.S. NeuroSurgical Holdings, Inc. | - USD | -Infinity% |
| Veltex Corporation | 838.65 Thousand USD | -537.328% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 1.12 Million USD | -376.343% |